Advanced search×

Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety

Brain Behav Immun (2011) PMID 21377524

Stress has been shown to facilitate ethanol withdrawal-induced anxiety. Defining neurobiological mechanisms through which stress has such actions is important given the associated risk of relapse. While CRF has long been implicated in the action of stress, current results show that stress elevates the cytokine TNF@a in the rat brain and thereby implicates cytokines in stress effects. In support of this view, prior TNF@a microinjection into the central amygdala (CeA) of rats facilitated ethanol withdrawal-induced anxiety-a response that could not be attributed to an increase in plasma corticosterone. To test for a possible interaction between cytokines and CRF, a CRF1-receptor antagonist (SSR125543) administered prior to the repeated administration of TNF@a or MCP-1/CCL2 reduced the magnitude of the withdrawal-induced anxiety. This finding provided evidence for cytokine action being dependent upon CRF. Additionally, the sensitizing effect of stress on withdrawal-induced anxiety was reduced by treating the repeated stress exposure prior to ethanol with the MEK inhibitor SL327. Consistent with cytokines having a neuromediator function distinct from a neuroimmune action, TNF@a increased firing rate and GABA release from CeA neurons. Thus, an interaction of glial and neuronal function is proposed to contribute to the interaction of stress and chronic ethanol. Interrupting this potential glial-neuronal interaction could provide a novel means by which to alter the development of emotional states induced by stress that predict relapse in the alcoholic.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.bbi.2011.02.018
Version: za2963e q8zab q8zb6 q8zc2 q8zd8 q8zed q8zfb q8zg8

Similar articles you may find interesting…

  1. Developmental expression and distribution of GABA(A) receptor α1-, α3- and β2-subunits in pig brain.

    Dev Neurosci 33(2):99-109 (2011) PMID 21613774

    We examined the protein expression pattern and distribution of GABA type A (GABA(A)) receptor α(1)-, α(3)- and β(2)-subunits in the parietal cortex and hippocampus of the developing piglet brain. Four perinatal ages were studied; 14 days preterm (P-14), 10 days preterm (P-10), day of birth (P0) a...
  2. [GABA: a functional duality? Transition during neurodevelopment].

    Rev Neurol 52(11):665-75 (2011) PMID 21563118

    Gamma-aminobutyric acid (GABA) is the most important inhibitory-type neurotransmitter and its actions are mediated by ionotropic (GABA(A)) and metabotropic (GABA(B)) type receptors, which are widely distributed throughout the tissue of the central nervous system. To r...
  3. Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors.

    Neuropsychopharmacology 36(8):1703-13 (2011) PMID 21490590 PMCID PMC3138652

    We examined whether blockade of prefrontal cortex (PFC) GABA(A) receptors with bicuculline (BMI) impairs attention in rats using the 5-choice serial reaction time task (5CSRTT). For comparison, we also examined whether administration of the GABA(A) receptor agonist muscimol (MUS) would improve atten...